文献速递眼底病与葡萄膜炎

印度北部贝伐珠单抗玻璃体腔注射后嗜麦芽窄食单胞菌聚集性眼内炎的特征与结局

Cluster endophthalmitis due to Stenotrophomonas maltophilia following intravitreal bevacizumab: outcomes of patients from North India.
PubMed 文献 · Br J Ophthalmol · 2018-11-12

这项回顾性研究纳入28例(23男,平均59.07±13岁)接受玻璃体腔贝伐珠单抗注射后发生聚集性眼内炎的患者,分离出嗜麦芽窄食单胞菌。所有患者均在24-48小时内出现疼痛性视力下降,根据炎症严重程度行首次玻璃体切除或穿刺注药,最终所有患眼得以保留,多数恢复注射前最佳矫正视力与眼压。

要点

  • 注射后24-48小时内出现疼痛性视力下降需警惕聚集性眼内炎。
  • 根据炎症严重程度选择首次玻璃体切除或穿刺注药,持续炎症者需玻璃体切除。
  • 早期玻璃体切除、及时玻璃体腔抗生素及与微生物学家密切沟通有助保留患眼。

核心结论

  • 嗜麦芽窄食单胞菌可污染医院表面与供水,导致玻璃体腔贝伐珠单抗注射后聚集性眼内炎,早期玻璃体切除联合玻璃体腔抗生素可保留所有患眼。

研究设计与样本

  • 回顾性研究纳入28例(23名男性)接受玻璃体腔贝伐珠单抗注射后发生眼内炎的患者,平均年龄59.07±13岁,复习人口学、最佳矫正视力、临床特征、微生物学与处理。

主要发现

  • 所有患者均在注射后24-48小时内出现疼痛性视力下降。
  • 28眼中12眼有眼睑及角膜水肿、眼压升高(注射前后平均眼压差4.42 mmHg,p=0.005)及类中毒性眼前段综合征表现。
  • 16眼表现为角膜透明、严重玻璃体炎和介质混浊差,其中3眼有后部前房积脓。

关键数值与推荐

  • 眼压变化:注射前后平均眼压差4.42 mmHg(p=0.005)。
  • 最佳矫正视力:注射前0.77±0.48,注射后首次2.52±0.82,1个月0.88±0.66。

临床怎么用

  • 对玻璃体腔注射后24-48小时内疼痛性视力下降者应高度怀疑眼内炎并紧急处理。
  • 根据炎症严重程度选择首次玻璃体切除或穿刺注药,持续炎症者及时行玻璃体切除。
  • 早期玻璃体切除、及时玻璃体腔抗生素并与微生物学家密切沟通有助于保留患眼。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To study features, management and outcomes of cluster endophthalmitis following intravitreal bevacizumab (BCZ) injection in North India. METHODS: In this retrospective study, 28 patients (23 men) (mean age of 59.07±13 years) who received intravitreal injection of BCZ were included. Demographic details, best corrected visual acuity (BCVA), clinical features, microbiological findings and management of patients who developed endophthalmitis after injection of contaminated BCZ injections were reviewed. The organism isolated was Stenotrophomonas maltophilia. RESULTS: All patients suffered from painful diminution of vision within 24-48 hours. Of the 28 eyes, 12 had lid and corneal oedema, raised intraocular pressure (IOP) (difference between mean preinjection and postinjection IOP: 4.42 mm Hg; p=0.005) and toxic anterior segment syndrome-like picture. 16 eyes presented with clear cornea, severe vitritis and poor media clarity. Among these, three eyes showed posterior hypopyon. Seventeen eyes underwent primary pars plana vitrectomy (PPV) and intravitreal vancomycin+ceftazidime based on severity of inflammation. Eleven eyes underwent primary tap and inject. Among these, four eyes required PPV due to persistent inflammation. Eleven eyes showed positive staining for Gram-negative bacilli. Seven eyes were culture positive for S. maltophilia. Mean preinjection BCVA was 0.77±0.48. The first recorded postinjection BCVA was 2.52±0.82. BCVA (at 1 month) improved to 0.88±0.66. CONCLUSIONS: S. maltophilia can be found contaminating hospital surfaces and water supply. Early PPV, prompt intravitreal antibiotics and close communication with microbiologists greatly aided in salvaging all eyes from our cohort. Majority of the patients recovered their preinjection BCVA and IOP and achieved quiescence of inflammation.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Agarwal AK, Aggarwal K, Samanta R, et al. Cluster endophthalmitis due to Stenotrophomonas maltophilia following intravitreal bevacizumab: outcomes of patients from North India. Br J Ophthalmol. 2018. PMID: 30420442. doi:10.1136/bjophthalmol-2018-313131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。